Literature DB >> 2058482

MR imaging of phenylketonuria.

D W Shaw1, K R Maravilla, E Weinberger, J Garretson, C M Trahms, C R Scott.   

Abstract

Cranial MR imaging was performed on nine patients (13-27 years old) with classical phenylketonuria in order to define the spectrum of abnormal findings and to determine if these could be related to clinical or biochemical findings. MR abnormalities consistent with demyelination were found in varying degrees in a distribution corresponding to previous histopathologic studies. Specifically, increased signal was seen on T2-weighted sequences, most marked in the periventricular deep cerebral white matter. These changes were more prominent posteriorly, especially about the optic radiations. Comparison with clinical history and MR findings in this small series revealed that patients with adequate dietary control of phenylalanine levels had less severe white matter abnormalities than did patients with poorly controlled phenylalanine intake.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2058482      PMCID: PMC8333023     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  9 in total

1.  Pediatric neuroradiology.

Authors:  W S Ball
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

2.  Decreasing choline signal--a marker of phenylketonuria?

Authors:  M Dezortová; L Hejcmanová; M Hájek
Journal:  MAGMA       Date:  1996 Sep-Dec       Impact factor: 2.310

3.  Diffusion MRI findings in phenylketonuria.

Authors:  R N Sener
Journal:  Eur Radiol       Date:  2003-02-18       Impact factor: 5.315

4.  Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations.

Authors:  V Leuzzi; S Rinalduzzi; F Chiarotti; P Garzia; G Trasimeni; N Accornero
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

5.  Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients.

Authors:  V Leuzzi; G Trasimeni; G F Gualdi; I Antonozzi
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 6.  Neuroradiological and neurophysiological indices for neurometabolic disorders.

Authors:  A Kohlschütter
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

Review 7.  White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings.

Authors:  U Bick; K Ullrich; U Stöber; H Möller; G Schuierer; A C Ludolph; C Oberwittler; J Weglage; U Wendel
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

8.  The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study.

Authors:  V Leuzzi; M Tosetti; D Montanaro; C Carducci; C Artiola; C Carducci; I Antonozzi; M Burroni; F Carnevale; F Chiarotti; T Popolizio; G M Giannatempo; V D'Alesio; T Scarabino
Journal:  J Inherit Metab Dis       Date:  2007-01-23       Impact factor: 4.750

9.  An insight into the biochemistry of inborn errors of metabolism for a clinical neurologist.

Authors:  Rita Christopher; Bindu P Sankaran
Journal:  Ann Indian Acad Neurol       Date:  2008-04       Impact factor: 1.383

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.